Ninos P Adams, MD
Psychiatry · Bakersfield
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 2 carriers
- Offices
- 2
Offices
2 locations · County of Kern · Precision Psychiatric Services Inc
Plans that list them
4 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Adams’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A144452 · Current
Licensed to practise in California · since 2016 · expires 2028-05-31 · Autonomous University of Guadalajara Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$39,781
Medicare paid this office $39,781 for 85 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $23,974 | $106 |
| Psychiatric diagnostic evaluation with medical services | 43 | $7,112 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $5,143 | $103 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,359 | $105 |
| Short return visit | 14 | $818 | $31 |
Who their Medicare patients are
85 Original Medicare patients in 2024. Average age 46 · Under 65 87% · 85 and older 0% · Women 41% · Health risk score 1.20. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 47% · High blood pressure 46% · Diabetes 31% · COPD 15%.
The office billed $127,284, Medicare allowed $50,516 and paid $39,781; for 384 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 85 | 384 | 46 | 1.20 | $127,284 | $39,781 |
| 2023 | 89 | 229 | 49 | 1.05 | $65,797 | $21,623 |
| 2022 | 98 | 364 | 49 | 0.86 | $105,497 | $31,516 |
| 2021 | 48 | 145 | 47 | 1.21 | $33,652 | $9,847 |
| 2020 | 46 | 125 | 48 | 1.09 | $28,187 | $10,265 |
| 2019 | 63 | 162 | 48 | 1.16 | $34,062 | $8,093 |
| 2018 | 32 | 39 | 47 | 1.16 | $8,986 | $2,486 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $9,766 | $103 |
| Psychiatric diagnostic evaluation with medical services | 30 | $5,714 | $133 |
| Return visit (30+ min) | 11 | $423 | $38 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $14,208 | $92 |
| Psychiatric diagnostic evaluation with medical services | 23 | $3,528 | $153 |
| Long return visit (40+ min) | 19 | $2,113 | $111 |
| Return visit (30+ min) | 17 | $1,693 | $68 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,547 | $97 |
2021: 3 services
| Short return visit (20+ min) | 19 | $4,095 | $64 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $1,444 | $63 |
| Short return visit | 13 | $456 | $22 |
2020: 1 service
| Long return visit (40+ min) | 26 | $6,057 | $93 |
2019: 3 services
| Short return visit (20+ min) | 42 | $2,786 | $33 |
| Return visit (30+ min) | 21 | $2,563 | $83 |
| Short return visit (20+ min) | 18 | $855 | $39 |
2018: 1 service
| Short return visit (20+ min) | 15 | $570 | $38 |
Medicaid work
$83,738 in 2023
Medicaid paid $83,738 for 658 billed services this clinician did in 2023, up to 116 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 338 | $81,632 |
| Psychiatric diagnostic evaluation with medical services | 25 | $1,982 |
| Return visit (30+ min) | 202 | $123 |
| Short return visit (20+ min) | 93 | $0 |
| 2023 | 658 | 4 | 116 | $83,738 |
| 2019 | 343 | 9 | 16 | $6,330 |
See the largest Medicaid services in earlier years
2019
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 31 | $1,862 |
| GENERAL HEALTH PANEL | 44 | $1,791 |
| Measurement of vitamin D 25 hydroxy | 40 | $946 |
| Measurement of folic acid in serum | 42 | $532 |
| Blood test, lipids (cholesterol and triglycerides) | 44 | $475 |
| Hemoglobin A1C level | 44 | $352 |
| Measurement of free thyroxine | 44 | $326 |
| Syphilis test, non-treponemal antibody; qualitative (eg, VDRL, RPR, ART) | 12 | $46 |
| VITAMIN B-12 | 42 | $0 |
Drugs they prescribed that Part D paid
$138,397
Pharmacies billed $138,397 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 573) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
519 generic and 54 brand-name prescriptions · $138,397 in drug cost · 25 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Invega Sustenna | 36 | $109,190 | $3,033 |
| Clozapine | 22 | $1,013 | $46 |
| Haloperidol | 27 | $675 | $25 |
| Divalproex | 29 | $616 | $21 |
| Quetiapine | 50 | $547 | $11 |
See all 20 drugs
| Invega Sustenna | 36 | $109,190 | $3,033 |
| Clozapine | 22 | $1,013 | $46 |
| Haloperidol | 27 | $675 | $25 |
| Divalproex | 29 | $616 | $21 |
| Quetiapine | 50 | $547 | $11 |
| Mirtazapine | 22 | $406 | $18 |
| Divalproex Sodium Er | 21 | $396 | $19 |
| Olanzapine | 29 | $376 | $13 |
| Carbamazepine | 14 | $367 | $26 |
| Aripiprazole | 13 | $287 | $22 |
| Bupropion Xl | 29 | $279 | $10 |
| Sertraline | 14 | $187 | $13 |
| Trazodone | 45 | $166 | $4 |
| Gabapentin | 17 | $143 | $8 |
| Risperidone | 20 | $94 | $5 |
| Lorazepam | 13 | $80 | $6 |
| Fluoxetine | 20 | $72 | $4 |
| Buspirone | 11 | $48 | $4 |
| Clonazepam | 13 | $42 | $3 |
| Escitalopram | 11 | $30 | $3 |
Year by year
| 2024 | 573 | 88 | 0% (0) | 9% | $138,397 |
| 2023 | 565 | 93 | 0% (0) | None | $264,045 |
| 2022 | 469 | 79 | 0% (0) | 16% | $224,376 |
| 2021 | 895 | 65 | 0% (0) | 13% | $226,659 |
| 2020 | 1,245 | 83 | 0% (0) | 11% | $257,435 |
| 2019 | 1,575 | 125 | 0% (0) | 10% | $283,835 |
| 2018 | 987 | 125 | 0% (0) | 8% | $146,545 |
| 2017 | 258 | 54 | 0% (0) | 9% | $33,803 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Invega Sustenna | 64 | $214,752 | $3,355 |
| Aripiprazole | 16 | $2,662 | $166 |
| Quetiapine | 55 | $2,449 | $45 |
| Olanzapine | 52 | $1,544 | $30 |
| Carbamazepine | 13 | $985 | $76 |
| Bupropion Xl | 29 | $720 | $25 |
| Divalproex | 28 | $675 | $24 |
| Mirtazapine | 25 | $546 | $22 |
| Buspirone | 14 | $519 | $37 |
| Haloperidol | 16 | $465 | $29 |
| Trazodone | 33 | $398 | $12 |
| Risperidone | 17 | $391 | $23 |
| Gabapentin | 18 | $238 | $13 |
| Lorazepam | 21 | $235 | $11 |
| Fluoxetine | 22 | $124 | $6 |
| Sertraline | 13 | $106 | $8 |
2022: 18 drugs
| Invega Sustenna | 63 | $189,944 | $3,015 |
| Quetiapine | 28 | $1,871 | $67 |
| Aripiprazole | 14 | $1,602 | $114 |
| Olanzapine | 34 | $1,477 | $43 |
| Carbamazepine | 12 | $1,280 | $107 |
| Clozapine | 18 | $998 | $55 |
| Bupropion Xl | 18 | $625 | $35 |
| Haloperidol | 15 | $493 | $33 |
| Divalproex | 18 | $299 | $17 |
| Mirtazapine | 16 | $283 | $18 |
| Lorazepam | 12 | $255 | $21 |
| Risperidone | 18 | $250 | $14 |
| Sertraline | 21 | $208 | $10 |
| Gabapentin | 18 | $207 | $11 |
| Trazodone | 24 | $128 | $5 |
| Topiramate | 11 | $106 | $10 |
| Fluoxetine | 20 | $71 | $4 |
| Escitalopram | 11 | $67 | $6 |
2021: 27 drugs
| Invega Sustenna | 67 | $180,662 | $2,696 |
| Latuda | 11 | $15,344 | $1,395 |
| Quetiapine Fumarate Er | 12 | $4,509 | $376 |
| Aripiprazole | 31 | $2,241 | $72 |
| Quetiapine | 82 | $1,604 | $20 |
| Perphenazine | 11 | $1,539 | $140 |
| Carbamazepine | 15 | $1,535 | $102 |
| Clozapine | 32 | $1,502 | $47 |
| Bupropion Xl | 39 | $1,397 | $36 |
| Trazodone | 82 | $870 | $11 |
| Haloperidol | 30 | $777 | $26 |
| Olanzapine | 36 | $522 | $14 |
| Oxcarbazepine | 24 | $469 | $20 |
| Benztropine Mesylate | 31 | $288 | $9 |
| Fluoxetine | 60 | $240 | $4 |
| Divalproex | 22 | $229 | $10 |
| Fluvoxamine Maleate | 26 | $205 | $8 |
| Escitalopram | 24 | $201 | $8 |
| Lorazepam | 14 | $195 | $14 |
| Propranolol | 12 | $186 | $16 |
| Venlafaxine Hcl Er | 18 | $176 | $10 |
| Topiramate | 31 | $174 | $6 |
| Gabapentin | 21 | $159 | $8 |
| Clonazepam | 36 | $130 | $4 |
| Sertraline | 23 | $112 | $5 |
| Risperidone | 21 | $86 | $4 |
| Citalopram Hbr | 11 | $20 | $2 |
2020: 33 drugs
| Invega Sustenna | 71 | $174,029 | $2,451 |
| Aristada | 11 | $31,668 | $2,879 |
| Latuda | 13 | $26,931 | $2,072 |
| Clozapine | 62 | $3,652 | $59 |
| Aripiprazole | 28 | $2,890 | $103 |
| Bupropion Xl | 47 | $2,117 | $45 |
| Perphenazine | 14 | $2,083 | $149 |
| Quetiapine | 98 | $1,684 | $17 |
| Olanzapine | 72 | $1,051 | $15 |
| Haloperidol | 41 | $1,048 | $26 |
| Trazodone | 99 | $866 | $9 |
| Oxcarbazepine | 28 | $693 | $25 |
| Divalproex | 40 | $648 | $16 |
| Divalproex Sodium Er | 13 | $603 | $46 |
| Carbamazepine | 20 | $503 | $25 |
| Fluoxetine | 98 | $489 | $5 |
| Benztropine Mesylate | 41 | $432 | $11 |
| Clonazepam | 52 | $351 | $7 |
| Fluvoxamine Maleate | 28 | $350 | $12 |
| Propranolol | 16 | $325 | $20 |
| Risperidone | 49 | $237 | $5 |
| Temazepam | 15 | $235 | $16 |
| Topiramate | 37 | $234 | $6 |
| Venlafaxine Hcl Er | 22 | $215 | $10 |
| Hydroxyzine Pamoate | 18 | $210 | $12 |
| Lorazepam | 19 | $183 | $10 |
| Sertraline | 36 | $146 | $4 |
| Gabapentin | 19 | $136 | $7 |
| Hydroxyzine | 11 | $111 | $10 |
| Bupropion Hcl Sr | 13 | $107 | $8 |
| Zolpidem | 17 | $96 | $6 |
| Escitalopram | 14 | $40 | $3 |
| Citalopram Hbr | 15 | $29 | $2 |
2019: 37 drugs
| Invega Sustenna | 42 | $91,418 | $2,177 |
| Latuda | 34 | $66,366 | $1,952 |
| Aristada | 19 | $49,601 | $2,611 |
| Aripiprazole | 48 | $17,023 | $355 |
| Chlorpromazine | 23 | $11,904 | $518 |
| Venlafaxine Hcl Er | 28 | $2,779 | $99 |
| Olanzapine | 135 | $2,162 | $16 |
| Clozapine | 43 | $2,154 | $50 |
| Quetiapine | 83 | $1,765 | $21 |
| Divalproex Sodium Er | 34 | $1,420 | $42 |
| Bupropion Xl | 33 | $1,416 | $43 |
| Divalproex | 58 | $917 | $16 |
| Risperidone | 85 | $766 | $9 |
| Fluoxetine | 100 | $758 | $8 |
| Trazodone | 86 | $735 | $9 |
| Haloperidol | 31 | $690 | $22 |
| Clonazepam | 88 | $578 | $7 |
| Hydroxyzine Pamoate | 41 | $549 | $13 |
| Prazosin | 18 | $547 | $30 |
| Lorazepam | 41 | $444 | $11 |
| Duloxetine | 14 | $443 | $32 |
| Benztropine Mesylate | 37 | $383 | $10 |
| Propranolol | 21 | $382 | $18 |
| Gabapentin | 34 | $367 | $11 |
| Buspirone | 29 | $328 | $11 |
| Topiramate | 28 | $309 | $11 |
| Mirtazapine | 33 | $308 | $9 |
| Fluvoxamine Maleate | 24 | $284 | $12 |
| Lithium Carbonate | 30 | $240 | $8 |
| Bupropion Hcl Sr | 23 | $216 | $9 |
| Zolpidem | 29 | $216 | $7 |
| Temazepam | 11 | $190 | $17 |
| Oxcarbazepine | 12 | $185 | $15 |
| Sertraline | 30 | $126 | $4 |
| Escitalopram | 19 | $108 | $6 |
| Citalopram Hbr | 15 | $49 | $3 |
| Paroxetine | 11 | $47 | $4 |
2018: 28 drugs
| Invega Sustenna | 32 | $76,150 | $2,380 |
| Latuda | 21 | $35,611 | $1,696 |
| Quetiapine Fumarate Er | 21 | $2,195 | $105 |
| Quetiapine | 96 | $2,126 | $22 |
| Divalproex Sodium Er | 25 | $1,266 | $51 |
| Aripiprazole | 29 | $1,195 | $41 |
| Olanzapine | 81 | $1,038 | $13 |
| Fluoxetine | 69 | $545 | $8 |
| Venlafaxine Hcl Er | 12 | $545 | $45 |
| Propranolol | 33 | $490 | $15 |
| Risperidone | 56 | $478 | $9 |
| Trazodone | 66 | $441 | $7 |
| Divalproex | 28 | $383 | $14 |
| Hydroxyzine Pamoate | 25 | $313 | $13 |
| Prazosin | 12 | $287 | $24 |
| Clonazepam | 65 | $266 | $4 |
| Escitalopram | 19 | $244 | $13 |
| Benztropine Mesylate | 30 | $227 | $8 |
| Buspirone | 19 | $204 | $11 |
| Bupropion Hcl Sr | 13 | $201 | $15 |
| Alprazolam | 12 | $155 | $13 |
| Sertraline | 38 | $154 | $4 |
| Lithium Carbonate | 19 | $147 | $8 |
| Gabapentin | 16 | $143 | $9 |
| Lorazepam | 16 | $132 | $8 |
| Mirtazapine | 16 | $98 | $6 |
| Zolpidem | 13 | $77 | $6 |
| Citalopram Hbr | 16 | $40 | $2 |
2017: 7 drugs
| Invega Sustenna | 11 | $21,120 | $1,920 |
| Quetiapine | 47 | $541 | $12 |
| Olanzapine | 18 | $202 | $11 |
| Sertraline | 21 | $115 | $5 |
| Fluoxetine | 15 | $95 | $6 |
| Trazodone | 13 | $80 | $6 |
| Benztropine Mesylate | 15 | $71 | $5 |
Money from drug and device companies
$989 in 2025
| 2025 | 6 | 8 | None | $989 |
| 2024 | 3 | 4 | None | $498 |
| 2023 | 3 | 3 | None | $328 |
| 2022 | 2 | 3 | None | $364 |
| 2021 | 5 | 6 | None | $706 |
| 2019 | 2 | 2 | None | $189 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alkermes | Lybalvi | $371 | 3 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $139 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $125 | 1 payment
|
| Abbvie | Vraylar | $125 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $121 | 1 payment
|
| Teva Pharmaceuticals USA | Uzedy | $108 | 1 payment
|
See all 8 published payments
| Otsuka America Pharmaceutical | Meals · 2025-11-13 | Rexulti | $125 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-06 | Caplyta | $121 |
| Teva Pharmaceuticals USA | Meals · 2025-09-18 | Uzedy | $108 |
| Abbvie | Meals · 2025-08-19 | Vraylar | $125 |
| Alkermes | Meals · 2025-07-16 | Lybalvi | $124 |
| Alkermes | Meals · 2025-05-19 | Lybalvi | $122 |
| Alkermes | Meals · 2025-05-14 | Aristada | $125 |
| Janssen Pharmaceuticals | Meals · 2025-03-26 | Invega Sustenna | $139 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $498
| Alkermes | Lybalvi | $244 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $128 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $125 | 1 payment
|
2023: $328
| Janssen Pharmaceuticals | Invega Sustenna | $125 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $125 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $78 | 1 payment
|
2022: $364
| Alkermes | Lybalvi | $239 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $125 | 1 payment
|
2021: $706
| Alkermes | Aristada | $237 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $125 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $125 | 1 payment
|
| Iti | Caplyta | $122 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $96 | 1 payment
|
2019: $189
| Alkermes | Aristada | $100 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $89 | 1 payment
|
Professional record
- NPI
- 1295143907
- Licence
- CA A144452California A144452: Current · expires 2028-05-31
- Group
- County of Kern · Precision Psychiatric Services Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- Po Box 1238, Salida, CA, 95368
- NPI first listed
- 2014-07-25
- NPI last updated
- 2024-05-16
- NPI record certified
- 2024-05-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1600 E Belle Ter, Bakersfield, CA, 93307 · 1100 S Akers St, Visalia, CA, 93277